These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35120041)

  • 1. Association of Metformin Use During Hospitalization and Mortality in Critically Ill Adults With Type 2 Diabetes Mellitus and Sepsis.
    Gómez H; Del Rio-Pertuz G; Priyanka P; Manrique-Caballero CL; Chang CH; Wang S; Liu Q; Zuckerbraun BS; Murugan R; Angus DC; Kellum JA
    Crit Care Med; 2022 Jun; 50(6):935-944. PubMed ID: 35120041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Preoperative Metformin Exposure and Postoperative Outcomes in Adults With Type 2 Diabetes.
    Reitz KM; Marroquin OC; Zenati MS; Kennedy J; Korytkowski M; Tzeng E; Koscum S; Newhouse D; Garcia RM; Vates J; Billiar TR; Zuckerbraun BS; Simmons RL; Shapiro S; Seymour CW; Angus DC; Rosengart MR; Neal MD
    JAMA Surg; 2020 Jun; 155(6):e200416. PubMed ID: 32267474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
    Pérez-Belmonte LM; Torres-Peña JD; López-Carmona MD; Ayala-Gutiérrez MM; Fuentes-Jiménez F; Jorge Huerta L; Muñoz JA; Rubio-Rivas M; Madrazo M; Garcia MG; Montes BV; Sola JF; Ena J; Ferrer RG; Pérez CM; Ripper CJ; Lecumberri JJN; Acedo IEA; Canteli SP; Cosío SF; Martínez FA; Rodríguez BC; Pérez-Martínez P; Ramos-Rincón JM; Gómez-Huelgas R;
    BMC Med; 2020 Nov; 18(1):359. PubMed ID: 33190637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study*.
    Horkan CM; Purtle SW; Mendu ML; Moromizato T; Gibbons FK; Christopher KB
    Crit Care Med; 2015 Feb; 43(2):354-64. PubMed ID: 25474534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
    Tseng CH
    J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between prior metformin therapy and sepsis in diabetes patients: a nationwide sample cohort study.
    Oh TK; Song IA
    J Anesth; 2020 Jun; 34(3):358-366. PubMed ID: 32146543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study.
    Chen TH; Li YR; Chen SW; Lin YS; Sun CC; Chen DY; Mao CT; Wu M; Chang CH; Chu PH; Wu VC
    Cardiovasc Diabetol; 2020 Nov; 19(1):189. PubMed ID: 33167990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
    Roumie CL; Hung AM; Greevy RA; Grijalva CG; Liu X; Murff HJ; Elasy TA; Griffin MR
    Ann Intern Med; 2012 Nov; 157(9):601-10. PubMed ID: 23128859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus.
    Ma Z; Patel N; Vemparala P; Krishnamurthy M
    Sci Rep; 2022 Apr; 12(1):5553. PubMed ID: 35365744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin Use Is Associated with Fewer Complications in Patients with Type-2 Diabetes Undergoing Total Knee Arthroplasty: A Propensity Score-Matched Analysis.
    Wilson JM; Farley KX; Broida SE; Bradbury TL; Guild GN
    J Bone Joint Surg Am; 2021 Apr; 103(7):601-608. PubMed ID: 33787554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
    Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
    Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study.
    Christiansen C; Johansen M; Christensen S; O'Brien JM; Tønnesen E; Sørensen H
    Crit Care; 2013 Sep; 17(5):R192. PubMed ID: 24018017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic acidosis in medical ICU - the role of diabetes mellitus and metformin.
    Hloch O; Charvat J; Masopust J; Havlin J
    Neuro Endocrinol Lett; 2012; 33(8):792-5. PubMed ID: 23391971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monocyte/lymphocyte ratio as a predictor of 30-day mortality and adverse events in critically ill patients: analysis of the MIMIC-III database].
    Li Y; Liu Y; Zhou C; Zhang Z; Zuo X; Li J; Cao Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 May; 33(5):582-586. PubMed ID: 34112297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients.
    van Vught LA; Scicluna BP; Hoogendijk AJ; Wiewel MA; Klein Klouwenberg PM; Cremer OL; Horn J; Nürnberg P; Bonten MM; Schultz MJ; van der Poll T
    Crit Care; 2016 Aug; 20(1):252. PubMed ID: 27495247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*.
    Raghunathan K; Shaw A; Nathanson B; Stürmer T; Brookhart A; Stefan MS; Setoguchi S; Beadles C; Lindenauer PK
    Crit Care Med; 2014 Jul; 42(7):1585-91. PubMed ID: 24674927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
    Ma Z; Krishnamurthy M
    PLoS One; 2023; 18(2):e0282210. PubMed ID: 36821577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
    Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
    Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study.
    Zhou J; Zhang G; Chang C; Chou OHI; Lee S; Leung KSK; Wong WT; Liu T; Wai AKC; Cheng SH; Zhang Q; Tse G
    Acta Diabetol; 2022 May; 59(5):697-709. PubMed ID: 35112189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study.
    He S; Qian X; Chen Y; Shen X; Zhang B; Chen X; Xu X; Li G
    J Diabetes Res; 2021; 2021():5534387. PubMed ID: 34222493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.